Pentagon pulls back testosterone screening guidelines shortly after release
The Pentagon released clinical guidance for mandatory testosterone screening on September 2, but rescinded it the next day without explanation. The guidance included questionnaires and potential hormone therapy, which health experts criticized as potentially harmful. The Pentagon said the document is being updated and interim guidance remains in effect.
This summary is AI-generated and original to Mobble; the linked article is the authoritative source.
Original headline: “Pentagon rescinds new testosterone screening policy without explanation.” Browse more stories.